Company Filing History:
Years Active: 2008
Title: Maria A DeBernardi: Innovator in Cancer Research
Introduction
Maria A DeBernardi is a prominent inventor based in Potomac, MD (US). She has made significant contributions to the field of cancer research, particularly in the area of drug resistance. Her innovative work focuses on methods for diagnosing drug-resistant cancer cells and identifying effective chemotherapeutic agents.
Latest Patents
Maria A DeBernardi holds a patent for "Methods for diagnosing drug-resistant cancer cells or for identifying chemotherapeutic agents by measuring anomalous intracellular ion and/or second messenger dynamics." This invention relates to identifying drug-resistant and drug-sensitive cells, such as breast cancer and brain tumor cells, by measuring the differences in ion and second messenger dynamics. The patent outlines methods for screening compounds that can influence ionic dynamics in cells, which can aid in determining drug resistance and designing personalized cancer therapies. She has 1 patent to her name.
Career Highlights
Maria is associated with Atto Bioscience Inc., where she continues her research and development efforts. Her work has the potential to revolutionize cancer treatment by providing new insights into how cancer cells respond to therapies.
Collaborations
One of her notable collaborators is Gary Brooker, with whom she has worked closely on various projects related to cancer research.
Conclusion
Maria A DeBernardi's innovative contributions to cancer research highlight her dedication to improving treatment options for patients. Her work in understanding drug resistance is crucial for the future of personalized medicine in oncology.